Delivery Order V797P4155B-VA24612F1235

This is a firm fixed-price purchase order contract awarded by the Veterans Integrated Service Network 6 (VISN 6), a civilian agency, to Shire Regenerative Medicine, Inc. (doing business as Advanced Biohealing.com) for the product DERMAGRAFT. The contract has a ceiling value of $4,081.56 and an ultimate completion date of June 26, 2011. The contract was awarded on May 27, 2011 and was not set aside for any particular type of business. The award does not indicate the existence of any major...

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading regenerative medicine company specializing in advanced wound care, surgical biologics, and tissue regeneration products. The contract is for the supply of the company's APLIGRAF product, a specialized skin substitute used in medical treatments. The $1,239.95 fixed-price contract with economic price adjustment has a completion date of November 13, 2024....

This federal contract award, with ID SPE2DE21D0005|SPE2D625F31DY, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a for-profit manufacturer of regenerative medicine products headquartered in Canton, Massachusetts. The $1,239.95 delivery order is for the supply of APLIGRAF, a skin substitute product, and does not utilize any set-aside designation. Organogenesis is an established vendor for the DLA and the Department of Veterans Affairs (VA), providing...

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a for-profit medical device manufacturer based in Canton, Massachusetts. The contract, valued at $1,239.95, is for the provision of APLIGRAF, a skin substitute product used for advanced wound care. The contract does not have a set-aside designation, indicating Organogenesis competes as a standard commercial vendor. Organogenesis has established itself as a key...

Organogenesis Inc., a regenerative medicine company headquartered in Canton, Massachusetts, was awarded a delivery order valued at $1,239.95 for APLIGRAF, an advanced wound care and tissue regeneration product. The contract was issued on October 14, 2025, with an ultimate completion date of October 17, 2025, and carries fixed-price pricing with economic price adjustment terms. No set-aside designation was utilized for this award. The contract is funded through the Defense Logistics Agency's...

Organogenesis Inc., a regenerative medicine company based in Canton, Massachusetts, received a delivery order for APLIGRAF from the Defense Logistics Agency (DLA) Medical Supply Chain on October 15, 2025. This fixed-price contract with economic price adjustment carries a ceiling value of $2,479.90 and is scheduled for completion by October 20, 2025. The award was made without any set-aside designation, indicating Organogenesis competed as a standard commercial vendor. APLIGRAF is an advanced...

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a regenerative medicine company based in Canton, Massachusetts. The contract is for the provision of APLIGRAF, a skin substitute product, with a fixed price and economic price adjustment pricing type. The contract has a ceiling value of $1,239.95 and runs through June 3, 2025. Organogenesis is a for-profit manufacturer registered in the System for Award...

This is a federal contract award from the Defense Logistics Agency (DLA) to Organogenesis Inc., a regenerative medicine company headquartered in Canton, Massachusetts. The award, valued at $1,239.95, is for the delivery of APLIGRAF, a skin substitute product. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) vehicle held by Organogenesis with the DLA, valued at $49.5 million, for wound care dressings and medical supplies. This IDC was awarded as a total small...

The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a Delivery Order contract worth $3,719.85 to Organogenesis Inc., a leading regenerative medicine company. The contract is for the supply of the APLIGRAF product, which is an advanced wound care and tissue regeneration solution. Organogenesis is a for-profit organization and manufacturer of goods that has held various federal contracts, including a $30 million multiple-award Federal Supply Schedule contract with the...

Organogenesis Inc., a regenerative medicine company based in Canton, Massachusetts, received a delivery order award from the Defense Logistics Agency's Medical Supply Chain on May 6, 2025, for APLIGRAF products with a ceiling value of $1,239.95. This fixed-price delivery order with economic price adjustment pricing carries an ultimate completion date of May 9, 2025. The award utilizes no set-aside designation, indicating competition on a standard commercial basis. APLIGRAF is an advanced wound...